TW217417B - - Google Patents

Info

Publication number
TW217417B
TW217417B TW081109457A TW81109457A TW217417B TW 217417 B TW217417 B TW 217417B TW 081109457 A TW081109457 A TW 081109457A TW 81109457 A TW81109457 A TW 81109457A TW 217417 B TW217417 B TW 217417B
Authority
TW
Taiwan
Prior art keywords
group
lower alkyl
formula
alkyl group
atom
Prior art date
Application number
TW081109457A
Other languages
English (en)
Chinese (zh)
Original Assignee
Manyu Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manyu Seiyaku Kk filed Critical Manyu Seiyaku Kk
Application granted granted Critical
Publication of TW217417B publication Critical patent/TW217417B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TW081109457A 1991-12-04 1992-11-25 TW217417B (OSRAM)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34767091 1991-12-04
JP35373891 1991-12-18
JP23420792 1992-08-10

Publications (1)

Publication Number Publication Date
TW217417B true TW217417B (OSRAM) 1993-12-11

Family

ID=27332096

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081109457A TW217417B (OSRAM) 1991-12-04 1992-11-25

Country Status (6)

Country Link
EP (1) EP0555537B1 (OSRAM)
AT (1) ATE197305T1 (OSRAM)
AU (1) AU657585B2 (OSRAM)
CA (1) CA2084163C (OSRAM)
DE (1) DE69231546T2 (OSRAM)
TW (1) TW217417B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121724A1 (en) 1993-04-21 1994-10-22 Toshifumi Watanabe Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction
CA2135151A1 (en) * 1993-11-08 1995-05-09 Mitsuhiro Wakimasu Cyclic hexapeptides, their production and use
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
EP0821670A1 (en) * 1995-04-21 1998-02-04 Novartis AG N-aroylamino acid amides as endothelin inhibitors
WO1997011961A1 (en) * 1995-09-26 1997-04-03 Takeda Chemical Industries, Ltd. Peptide derivatives having endothelin receptor antagonistic activity
AU2001239896A1 (en) 2000-03-16 2001-10-03 Sepracor, Inc. Peptidomimetic ligands for cellular receptors and ion channels
DE10105077A1 (de) * 2001-02-05 2002-08-08 Febit Ferrarius Biotech Gmbh Hybrid-Schutzgruppe
ATE327744T1 (de) 2001-03-20 2006-06-15 Sanol Arznei Schwarz Gmbh Neue verwendung von peptidverbindungen bei der behandlung von nicht-neuropathischem entzündungsschmerz
PT1243263E (pt) 2001-03-21 2003-03-31 Sanol Arznei Schwarz Gmbh Nova utilizacao de uma classe peptidica de composto para o tratamento de alodinia ou de outros tipos diferentes de dor cronica ou fantasma
WO2005053667A1 (en) 2003-12-02 2005-06-16 Schwarz Pharma Ag Novel use of peptide compounds for treating central neuropathic pain
AU2005232395B2 (en) 2004-04-16 2010-09-09 Schwarz Pharma Ag Use of peptidic compounds for the prophylaxis and treatment of chronic headache
EP1604655A1 (en) 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating pain in trigeminal neuralgia
MX2007002269A (es) 2004-08-27 2007-06-15 Sanol Arznei Schwarz Gmbh Uso novedoso de compuestos peptidos para tratar dolor por c??ncer de huesos, dolor inducido por quimioterapia y nucleosidos.
EP2462990B2 (en) 2006-06-15 2018-04-18 UCB Pharma GmbH Pharmaceutical composition comprising lacosamide and levetiracetam with synergistic anticonvulsant effect
WO2017024032A2 (en) 2015-08-03 2017-02-09 Enb Therapeutics, Llc Compositions and methods for treating cancers associated with etbr activation
GB201712282D0 (en) 2017-07-31 2017-09-13 Nodthera Ltd Selective inhibitors of NLRP3 inflammasome
EP3713571A4 (en) 2018-01-12 2021-08-25 ENB Therapeutics, Inc. DEUTERATED COMPOUNDS, COMPOSITIONS AND TREATMENT METHODS FOR CANCERS ASSOCIATED WITH ETBR ACTIVATION
WO2019191721A1 (en) * 2018-03-30 2019-10-03 Enb Therapeutics, Inc. Etbr antagonist compounds, compositions, and uses
EP4089102A1 (en) * 2021-05-14 2022-11-16 Insusense ApS Modulators of sortilin activity
CN120271660B (zh) * 2025-06-09 2025-08-19 杭州肽佳生物科技有限公司 一种高效选择性拮抗剂bq-788的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284828A (en) * 1990-05-14 1994-02-08 Fujisawa Pharmaceutical Co. Ltd. Peptide compound and its preparation
CA2043741C (en) * 1990-06-07 2003-04-01 Kiyofumi Ishikawa Endothelin antagonistic peptide derivatives
GB9123967D0 (en) * 1991-11-12 1992-01-02 Fujisawa Pharmaceutical Co New compound and its preparation

Also Published As

Publication number Publication date
CA2084163C (en) 2004-06-29
ATE197305T1 (de) 2000-11-15
EP0555537A2 (en) 1993-08-18
DE69231546D1 (de) 2000-12-07
AU657585B2 (en) 1995-03-16
AU2983892A (en) 1993-06-10
DE69231546T2 (de) 2001-05-31
EP0555537B1 (en) 2000-11-02
CA2084163A1 (en) 1993-06-05
EP0555537A3 (en) 1994-11-02

Similar Documents

Publication Publication Date Title
TW217417B (OSRAM)
DE69130408D1 (de) Endothelinantagonistische Peptidderivate
DE122008000051I1 (de) 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel
CA2238410A1 (en) Novel indole-2,3-dione-3-oxime derivatives
ES2126075T3 (es) Derivados biciclicos nitrogenados como inhibidores de la propil-endopeptidasa.
WO2002048122A3 (en) Benzamidine derivatives
CA2081891A1 (en) Quinolizinone type compounds
SE8601826L (sv) 5-pyrimidinkarboxamider och beredningar for behandling av leukemi och tumorer
BG105373A (en) 2-phenylpyran-4-one derivatives
EP0878196A4 (en) INHIBITORS OF KAINIC ACID NEUROTOXICITY AND PYRIDOTHIAZINE DERIVATIVES
DE69230415D1 (de) Cephalosporinverbindungen und ihre pharmazeutische Präparate
DE69534407D1 (de) Dihydro-2,3-Benzodiazepinderivate
PT728748E (pt) Novos derivados da benzodiazepina
DE69334353D1 (de) Benzodiazepin-Derivate, verwendbar als CCK-Rezeptor Antagonisten
AU532634B2 (en) Thiazolyl derivatives
TW366344B (en) Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives and pharmaceutical composition using the same
EP0513398A4 (en) Intermediate for synthesis of carbapenem and production of said intermediate

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent